Reducing Fluid Pressure in Melanoma Tumors with TNF-alpha
Author Information
Author(s): CA Kristensen, M Nozue, Y Boucher, RK Jain
Primary Institution: Harvard Medical School, Massachusetts General Hospital
Hypothesis
Can TNF-alpha reduce interstitial fluid pressure in human melanoma xenografts?
Conclusion
TNF-alpha significantly reduced interstitial fluid pressure in melanoma tumors after treatment.
Supporting Evidence
- TNF-alpha reduced interstitial fluid pressure to 54-64% of control values after 5 hours.
- Mean arterial blood pressure decreased to 70% of control values after TNF-alpha treatment.
- No significant difference in tumor size was found between treated and untreated groups.
Takeaway
This study found that a treatment called TNF-alpha can help lower the pressure inside melanoma tumors, which might help deliver medicine better.
Methodology
Three human melanoma cell lines were injected into nude mice, and the effects of TNF-alpha on interstitial fluid pressure and mean arterial blood pressure were measured.
Limitations
The pressure-lowering effect of TNF-alpha was not sustained beyond 24 hours.
Participant Demographics
Male nude mice were used for the experiments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website